Skip to content

Study · Measured the body's own peptide · 1987

1 result

Effects of Newcastle disease virus administration to mice on the metabolism of cerebral biogenic amines, plasma corticosterone, and lymphocyte proliferation.

Dunn AJ, Powell ML, Moreshead WV, Gaskin JM, Hall NR

Brain, behavior, and immunity1 Sept 1987Cited by 49 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In mice, plasma thymosin alpha‑1 concentrations were not altered by Newcastle disease virus administration or by hypophysectomy.

    In plain wordsIn mice, the body's own thymosin alpha‑1 levels in blood did not change after a virus or removal of the pituitary gland.

    Outcome
    No significant changePlasma thymosin alpha 1 after Newcastle disease virus or hypophysectomy
    Study

    mousen: not reported in source

    mice given Newcastle disease virus, with hypophysectomized and sham-operated groups
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Thymosin alpha 1 concentrations in the plasma were not altered by NDV or hypophysectomy.
    1 context sentence
    Title · context
    Effects of Newcastle disease virus administration to mice on the metabolism of cerebral biogenic amines, plasma corticosterone, and lymphocyte proliferation.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.